CBD Could Kill Antibiotic-Resistant Bacteria

cbd oil, cannabidiol, cannabinoid-5358409.jpg

The antibacterial properties of the cannabis plant (hemp, marijuana) can be used to create a new type of antibiotic that can kill bacteria that are resistant to antibiotic treatment. 

According to a new study conducted and published in January 2021 at the University of Queensland (UQ) in Australia by Professor Mark Blaskovitz and his partners, cannabidiol (CBD) may kill the bacteria responsible for gonorrhoea, meningitis and Legionnaires’ disease.


In Australia, gonorrhea is the second most severe sexually transmitted infection, and there is not yet a single antibiotic reliable to treat because these bacteria are particularly effective in developing antibiotic resistance. The treatment of the disease is through taking antibiotics. In the past, penicillin-resistant bacteria were used for this purpose, but in light of the emergence of penicillin-resistant bacteria and its derivatives, drugs are now used from the cephalosporin group that began commercial use in 1964.


Legionnaires’ disease

Legionellosis is an infectious disease caused by the bacterium Legionella pneumophilia. Since the symptoms are similar to pneumonia, this causes misdiagnation. The disease can be treated with antibiotics if it is detected in time. Five to thirty percent of patients die from the disease. Between 8,000 and 18,000 people have the disease each year in the United States.

Legionnaires disease


Meningitis Is an acute inflammatory disease of the soft membranes of the brain and spinal cord, caused mainly by bacterial and viral infection, but in some cases also from other microorganisms such as fungal and parasitic. Most cases of meningitis are caused by a viral infection – 85%. A bacterial disease (15%) is a life-threatening and life-threatening disease, and therefore in a bacterial disease, medical teams will begin providing broad-spectrum antibiotics even before receiving the microbiological laboratory’s response regarding the cause of the disease.

Tablet with the diagnosis Meningitis on the display

What did the research team at the University of Queensland find?

The research team at the University of Queensland has discovered that cannabidiol (CBD) can kill several different strains of bacteria, which may pave the way for a new type of antibiotic. It is worth noting that for 60 years no new antibiotics have been developed to treat these bacteria. “This is the first time CBD has been shown to kill certain types of Gram negative bacteria,” lead researcher and university associate Professor Mark Blaskovic said in a statement. “These bacteria have another external membrane, another line of defence that makes it difficult for antibiotics to penetrate. Gram-negative bacteria can cause gonorrhoea, meningitis, Legionnaires’ diseases and other infections that are difficult to treat with traditional antibiotics. “The findings are particularly exciting because new molecules of antibiotics have not been discovered and approved since the 1960s against gram-negative bacterial infections, and we can now consider designing new ANALOGUES of CBD with enhanced properties,” Blaskowitz explained. ‘We think cannabidiol kills bacteria by exploding their outer cell membranes, but we still don’t know exactly the mechanism of action in its entirety, and more research needs to be done.’ {At the beginning of the study on Phyto-connabinoids, before the discovery of the receptors CB1 and CB2, it was thought that the effect of PCBs was due to increased FLUIDITY of all cell membranes}

More Disclosures

The study also found that CBD can also kill gram-positive bacteria, including MRSA, an antibiotic-resistant form of staph bacteria increasingly found in health facilities. The researchers believe that cannabinoids can help kill these bacteria by breaking down biofilms — sticky layers of bacterial accumulation that help MRSA and other antibiotic-resistant bacteria protect against traditional antibiotics. (bacterial biofilms) These new studies will add to a growing body of research examining the antibiotic potential of cannabis. A study last year found that CBG (cannabigerol), another non-psychoactive cannabinoid, can kill MRSA bacteria and help break down treatment-resistant biofilms. Dental health researchers have also discovered that CBD, CBG and other cannabinoids can fight the formation of holes in the teeth by killing bacteria formed as dental plaques on the teeth and gums. In Israel, researchers are working on creating synthetic cannabinoid derivatives that can help combat gastrointestinal infections.

Read more about the properties of CBD in the treatment of Legionnaires’ disease, meningitis and gonorrhoea:

The antimicrobial potential of cannabidiol

Research establishes antibiotic potential for cannabis molecule

Bacteria and other infections for which there are studies and evidence that cannabinoids may help eliminate them:

Treponema pallidum (Syphilis), – Syphilis Staphylococci aureus and S. albus,- StephListeria monocytogenes,- ListeriaCandida albicans (Thrush)- CandidaNaegleria fowleri. – Brain-eating amoeba

Read more about:

Infectious diseases: types of diseases and prevention through CBD

Recommended products for the treatment of infectious diseases:

Related Articles